Company profile
Aclarion, Inc.
NASDAQ: ACON · Healthcare · Medical - Healthcare Information Services
PublicHQ Broomfield, CACIK 0001635077Reports USD
#1057 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
36DFH 37DQ 23GM 64SS 25
v0.1 · 65/100 weight · provisional
↑ balance-sheet leverage, revenue growth (YoY) · ↓ Piotroski F, operating margin
Methodology →Revenue TTM
$83.8k
Rev growth YoY (TTM)
+33.1%
Net income (FY)
-$7.2M
Employees
11
as of 2026-08-25
Market cap
$1.4M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$75.7k$75.7k2025
Net income-$7.2M-$7.2M2025
Operating income-$7.1M-$7.1M2025
Total assets$13.7M$13.7M2025
Liabilities$837.3k$837.3k2025
Equity$12.8M$12.8M2025
Revenue trend
FY2022 – FY2025 · USD
FY22
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Aclarion, Inc.’s revenue?
Aclarion, Inc. booked $75.7k in FY2025 revenue, growing 66% year over year — faster than most Healthcare companies we track, at a -9551.9% net margin.
Peers · Healthcare
Nemaura Medical Inc.——RegeneRx Biopharmaceuticals, Inc.——Sky Century Investment, Inc.28DSilo Pharma, Inc.39DIMAC Holdings, Inc.——Paranovus Entertainment Technology Ltd.——Key facts
CEOBrent Ness
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersBroomfield, CA
ExchangeNASDAQ: ACON
Employees11
IPO date2022-04-22
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.